|
1-Anilino-8-Naphthalene Sulfonate
|
DB04474 |
|
|
2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol
|
DB04471 |
|
|
4-Carboxyphenylboronic Acid
|
DB03140 |
|
|
3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril
|
DB03141 |
|
|
(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol
|
DB04472 |
|
|
CRA_10656
|
DB04470 |
|
|
Remtolumab
|
DB15128 |
[Remtolumab is under investigation in clinical trial NCT02433340 (Phase 2, Multicenter, Open-Label Extension (OLE) Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study).] |
|
Hydrogen
|
DB15127 |
[Hydrogen is under investigation in clinical trial NCT02830854 (Molecular Hydrogen for Cognitive Function and Performance in Elderly).] |
|
Pegadricase
|
DB15129 |
[Pegadricase is under investigation in clinical trial NCT01021241 (Safety and Efficacy Study of Intravenous Uricase-PEG 20).] |
|
PF-05241328
|
DB15124 |
[PF-05241328 is under investigation in clinical trial NCT01165736 (To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological Activity).] |
|
Dorzagliatin
|
DB15123 |
[Dorzagliatin is under investigation in clinical trial NCT03173391 (Long-term Efficacy and Safety of HMS5552 in T2DM).] |
|
IMG-7289
|
DB15126 |
[IMG-7289 is under investigation in clinical trial NCT03136185 (IMG-7289 in Patients With Myelofibrosis).] |
|
Belapectin
|
DB15125 |
[Belapectin is under investigation in clinical trial NCT02575404 (GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients).] |
|
GSK-239512
|
DB15120 |
[GSK-239512 is under investigation in clinical trial NCT00474513 (An Imaging Study to Investigate the Distribution of GSK239512 in the Brain.).] |
|
PCS-499
|
DB15122 |
[PCS-499 is under investigation in clinical trial NCT01487109 (A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients).] |
|
AT-001
|
DB15121 |
[AT-001 is under investigation in clinical trial NCT03062384 (AT-001 for Long-term Preservation of Brain Health in Aging).] |
|
4-Nitro-Inden-1-One
|
DB04479 |
|
|
Phosphomethylphosphonic Acid Adenosyl Ester
|
DB03148 |
|
|
N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine
|
DB04477 |
|
|
2-deazo-6-thiophosphate guanosine-5'-monophosphate
|
DB03146 |
|
